PT  - JOURNAL ARTICLE
AU  - See Mun Wong
AU  - Sarah Pacey
AU  - Opinder Sahota
TI  - Setting up a homecare service for zoledronic acid treatment of osteoporosis
AID  - 10.1136/ejhpharm-2015-000742
DP  - 2016 Nov 01
TA  - European Journal of Hospital Pharmacy
PG  - 364--365
VI  - 23
IP  - 6
4099  - http://ejhp.bmj.com/content/23/6/364.short
4100  - http://ejhp.bmj.com/content/23/6/364.full
SO  - Eur J Hosp Pharm2016 Nov 01; 23
AB  - Increasingly, patients are able to receive parenteral medicines at home rather than in the hospital setting. We describe our approach to setting up a new intravenous zoledronic acid homecare service for patients with osteoporosis. Initial evaluation of service feasibility demonstrated a marginal cost saving of approximately 6%, when the drug is administered via homecare compared with hospital day-case unit. Rigorous risk assessment was conducted prior to service initiation. Implementation strategies are outlined. Surveys confirmed that the majority of patients were highly satisfied with the home infusion service.